NCT06683833 Comparison Between Egyptian MTA, Biodentine Versus Calcium Hydroxide as Indirect Pulp Capping Materials In Permanent Teeth
| NCT ID | NCT06683833 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Cairo University |
| Condition | Deep Caries |
| Study Type | INTERVENTIONAL |
| Enrollment | 35 participants |
| Start Date | 2025-09-03 |
| Primary Completion | 2026-05-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 35 participants in total. It began in 2025-09-03 with a primary completion date of 2026-05-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Compare the clinical performance and patient satisfaction of Egyptian MTA, Biodentine versus Calcium Hydroxide as indirect pulp capping materials in permanent teeth
Eligibility Criteria
Inclusion Criteria: * Adult patients aged 22: 45 years old. * Males or females. * Patients with vital teeth with deep carious lesions. * Patients in good general health. * Good oral hygiene. * Co-operative patients who show interest to participate in the study. Exclusion Criteria: * Patients with systemic diseases. * Patients with known allergic or adverse reaction to the tested materials. * Patients with bad oral hygiene. * Patient who frequently use analgesic or any drugs that could mask the pain.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06683833 clinical trial?
This trial is open to participants of all sexes, aged 22 Years or older, up to 45 Years, studying Deep Caries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06683833 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT06683833 currently recruiting?
Yes, NCT06683833 is actively recruiting participants. Contact the research team at alaa.elsorogy@dentistry.cu.edu.eg for enrollment information.
Where is the NCT06683833 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06683833 clinical trial?
NCT06683833 is sponsored by Cairo University. The trial plans to enroll 35 participants.